Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

By | July 8, 2022
A recent study published in the Science journal depicted that mosaic receptor-binding domain (RBD) nanoparticles immunize from diverse sarbecovirus challenges, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), among animal models.